Quality of life scale in parkinson's disease PDQ-39 - (Brazilian Portuguese version) to assess patients with and without levodopa motor fluctuation

Arquivos de Neuro-Psiquiatria

Renata Guzzo Souza¹  Vanderci Borges¹  Sonia Maria Cesar De Azevedo Silva¹  Henrique Ballalai Ferraz¹ 

[1] ,Universidade Federal de São Paulo Department of Neurology Movement Disorders UnitSão Paulo SP ,Brazil

关键词: Parkinson's disease;    quality of life;    psychomotor performance;    levodopa;    doença de Parkinson;    qualidade de vida;    desempenho psicomotor;    levodopa;   

DOI  :  10.1590/S0004-282X2007000500010

来源: SciELO

【 摘 要 】

Quality of life (QoL) is an important treatment outcome indicator in Parkinson's disease (PD). The aim of this study is to assess the usefulness of the Parkinson's disease questionnaire - PDQ-39 (Brazilian Portuguese Version) in measuring QoL of PD patients with or without motor fluctuations. Fifty-six PD patients with mean disease duration of 7.4 years were assessed and 41 of them (73.3%) had motor fluctuations. The PDQ-39 has eight dimensions ranging from 0 to 100; being the higher the score, the worse the QoL. Comparing groups with and without motor fluctuations showed that the dimensions mobility, activities of daily living (ADL), communication and bodily discomfort scored higher in the fluctuating group. There was a tendency to see that the higher the Hoehn and Yahr (HY) scale stages, the higher the PDQ-39 scores. Patients suffering from the disease for more than five years had worse PDQ-39 scores only in the items ADL and communication, when compared with those with the disease for < 5 years. The PDQ-39 is an instrument that detects decrease in QoL of PD patients and the presence of motor fluctuations predicts QoL reduction.

【 授权许可】

CC BY   
 All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License